Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

A clinical-stage cancer immunotherapy company developing TTX-030, a first-in-class anti-CD39 antibody.

List your booth number for exhibitions, ask us